Pictet North America Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pictet North America Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$953K	Hold	6,020	–	–	0.08%	100
2026 Q1	$769K	Hold	6,020	–	–	0.08%	103
2025 Q4	$734K	Buy	+6,020	New	+$690K	0.07%	103

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

Pictet North America Advisors's XBI Position: Q2 2026 in Review

Pictet North America Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 6,020 shares worth $953K. The position accounts for 0.08% of the portfolio, ranked #100.

Pictet North America Advisors first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Pictet North America Advisors held 6,020 shares of State Street SPDR S&P Biotech ETF worth $953K as of Q2 2026.
Pictet North America Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.08% of Pictet North America Advisors's portfolio in Q2 2026, its #100 holding.
Pictet North America Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Pictet North America Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.